Pai KSR. Molecular docking and simulation studies of FDA approved drugs targeting Allosteric inhibition of Glycogen synthase kinase-3β . Jordan j. pharm. sci. [Internet]. 2026 Mar. 17 [cited 2026 May 2];19(1):52-70. Available from: https://jjournals.ju.edu.jo/index.php/jjps/article/view/2906